Progenics Pharmaceuticals, Inc. – FDA Inspection, Sep 11, 2017

Record Details

This FDA Inspection record concerns Progenics Pharmaceuticals, Inc., with an inspection on September 11, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Progenics Pharmaceuticals, Inc.
Inspection Date: September 11, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Tara K. Carmody (FDA Associated Person)

View Company Profile

ID · e7bb39c6-5ed3-4ade-b9d8-1c32003cd0d1

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1024928
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.50General responsibilities of sponsors

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Progenics Pharmaceuticals, Inc.

FDA Inspection

Progenics Pharmaceuticals, Inc.September 11, 2017